Lexicon Pharmaceuticals (LXRX) Total Debt (QoQ) (2011 - 2026)
Powered by 
Analysis
Lexicon Pharmaceuticals (LXRX) Total Debt (QoQ) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Lexicon Pharmaceuticals | 978.15 Mn | 787.54 Mn | 653,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.53% |
| Mar 31, 2026 | -8.00% |
| Dec 31, 2025 | -4.43% |
| Sep 30, 2025 | 0.71% |
| Jun 30, 2025 | -44.28% |
| Mar 31, 2025 | 0.40% |
| Dec 31, 2024 | 0.40% |
| Sep 30, 2024 | 0.40% |
| Jun 30, 2024 | -0.40% |
| Mar 31, 2024 | 0.39% |
| Dec 31, 2023 | 0.21% |
| Sep 30, 2023 | 0.51% |
| Jun 30, 2023 | 102.27% |
| Mar 31, 2023 | 0.55% |
| Dec 31, 2022 | 104.11% |
| Sep 30, 2022 | 0.72% |
| Jun 30, 2022 | 0.56% |
| Sep 30, 2021 | 0.15% |
| Jun 30, 2021 | 0.13% |
| Mar 31, 2021 | 0.12% |